Language selection

Search

Patent 2504960 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2504960
(54) English Title: METHOD FOR CONTROLLING WEEDS
(54) French Title: METHODE DE LUTTE CONTRE LES MAUVAISES HERBES
Status: Deemed expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 15/82 (2006.01)
  • A01H 1/04 (2006.01)
  • A01N 43/58 (2006.01)
  • A01N 43/653 (2006.01)
  • A01H 5/00 (2006.01)
(72) Inventors :
  • MATSUSHIMA, YUTAKA (Japan)
  • NAGASAWA, AKITSU (Japan)
(73) Owners :
  • SUMITOMO CHEMICAL COMPANY, LIMITED (Japan)
(71) Applicants :
  • SUMITOMO CHEMICAL COMPANY, LIMITED (Japan)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued: 2014-06-17
(22) Filed Date: 2005-05-16
(41) Open to Public Inspection: 2005-11-17
Examination requested: 2010-05-10
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
2004-146019 Japan 2004-05-17
2005-068714 Japan 2005-03-11

Abstracts

English Abstract

The present invention provides a method for controlling weeds comprising a step of applying one or more compounds to a cultivation area of a plant, to which a gene of cytochrome P450 showing activity of metabolizing a protoporphyrinogen IX oxidase inhibitory-type herbicidal compound has been introduced, wherein said compound to be applied to said area is selected from the group consisting of: ( 1 ) flufenpyr-ethyl, (2) 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl] -4-methy-5-(trifluoromethyl)-3(2H)-pyridazinone, (3) carfentrazone-ethyl, and (4) sulfentrazone; and the like.


French Abstract

La présente invention porte sur une méthode de lutte contre les mauvaises herbes comprenant une étape d'application d'un ou de plusieurs composés à une zone de culture d'une plante, dans laquelle un gène de cytochrome P450 présentant une activité de métabolisation d'un composé herbicide protoporphyrinogène IX de type inhibiteur d'oxydase a été introduit, où ledit composé à appliquer à ladite zone est sélectionné parmi le groupe comprenant : ( 1 ) flufenpyr-éthyle, (2) 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phényle] -4-méthy-5-(trifluorométhyle)-3(2H)-pyridazinone, (3) carfentrazone-éthyle et (4) sulfentrazone, et autres semblables.

Claims

Note: Claims are shown in the official language in which they were submitted.



The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:

1. A method for controlling weeds comprising a step of
applying at least one compound to a cultivation area of a plant
that comprises a heterologous DNA originally introduced by
transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence that
has 90% or more sequence identity to the amino acid sequence of
SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid sequence of
SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid sequence of
SEQ ID NO: 2; and
wherein said at least one compound to be applied to said
area is a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound which is:
(1) flufenpyr-ethyl,
(2) 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl]-4-
methyl-5-(trifluoromethyl)-3(2H)-pyridazinone,
(3) carfentrazone-ethyl, or
(4) sulfentrazone;
or any combination thereof.
2. The method according to claim 1, wherein said cytochrome
P450 is derived from actinomycetes.
3. The method according to claim 1, wherein said cytochrome
P450 is derived from actinomycetes belonging to Streptomyces.
4. A method for selecting a herbicidal compound resistant
plant, said method comprising:
58


1) a step of applying or adding at least one compound to
a cultivation area or a culturing area of a plant that comprises
a heterologous DNA originally introduced by transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence that
has 90% or more sequence identity to the amino acid sequence of
SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid sequence of
SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid sequence of
SEQ ID NO: 2; and
wherein said at least one compound to be applied or added
to said area is a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound which is:
(1) flufenpyr-ethyl,
(2) 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl]-4-
methyl-5-(trifluoromethyl)-3(2H)-pyridazinone,
(3) carfentrazone-ethyl, or
(4) sulfentrazone;
or any combination thereof; and
2) a step of selecting a plant which has survived the weed
control effect of said applied or added at least one compound.
5. The method according to claim 1, wherein said at least one
compound to be applied to said area is flufenpyr-ethyl.
6. The method according to claim 1, wherein said at least one
compound to be applied to said area is 2-[4-chloro-2-fluoro-5-(2-
propynyloxy)phenyl]-4-methyl-5-(trifluoromethyl)-3(2H)-
pyridazinone.
7. The method according to claim 1, wherein said at least one
compound to be applied to said area is carfentrazone-ethyl.

59


8. The method according to claim 1, wherein said at least one
compound to be applied to said area is sulfentrazone.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02504960 2005-05-16
METHOD FOR CONTROLLING WEEDS
BACKGROUND OF THE INVENTION
Field of tale Invention
The present invention relates to a method for controling
weeds.
Description of the Related Art
Protoporphyrinogen IX oxidase inhibitory-type herbicidal
compound 10 contained as an active ingredient in a weed control
agent. As a plant on which resistance to the protoporphyrinogen
IX oxidase inhibitory-type herbicidal compound has been
conferred, for instance, a plant expressing cytochrome P-450
derived from actinomyces such that the herbicidal compound is
metabolized for inactivation in the plant body ( for example,
described in International Patent Publication W00340370 and the
like) is known.
SUMMARY OF THE INVENTION
As to the herbicidal compound resistant plant,
phytotoxicity from the herbicidal compound tends to occur, since
herbicidal action of the herbicidal compound is generally
immediate. Therefore, search of more preferable combination
with the herbicidal compound used for the plant has been made.
The Ipresent invention provides,
1

CA 02504960 2005-05-16
1. a method for controlling weeds comprising a step of applying
one or more compounds to a cultivation area of a plant.
wherein to said plant, a DNA having a nucleotide sequence
encoding an amino acid sequence of cytochrome P450 showing
activity of metabolizing a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compound has been introduced
(hereinafter, said DNA may be referred to the present DNA, and
said plant may be referred to the present plant),
wherein said compound to be applied to said area is a
protoporphyrinogen IX oxidase inhibitory-type herbicidal
compound and selected from the group consisting of:
(1) flufenpyr-ethyl,
(2) 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl]
-4-methy-5-(trifluoromethyl)-3(2H)-pyridazinone,
(3) carfentrazone-ethyl, and
(4) sulfentrazone
(hereinafter, said method may be referred to the method for
controlling weeds of the present invention, and said compound
may be referred to the present herbicidal compound);
2. the method according to the above 1, wherein said cytochrome
P450 is cytochrome P450 derived from actinomyces;
3. the method according to the above 1, wherein said cytochrome
P450 is selected from the group consisting of:
(1) cytochrome P450 derived from actinomyces belonging
to Streptomyces,
2

CA 02504960 2005-05-16
(2) cytochrome P450 comprising an amino acid sequence
having 90% or more sequence homology to the amino acid sequence
of SEQ ID NO: 1 or 2,
(3) cytochrom P450 comprising the amino acid sequence of
SEQ ID NO: 1, and
(4) cytochrome P450 comprising the amino acid sequence
of SEQ ID NO: 2;
4. a method for selecting a herbicidal compound resistant plant,
said method comprising:
1) a step of applying or adding one or more compounds
to a cultivation area or a culturing area of a plant,
wherein to said plant, a DNA having a nucleotide
' sequence encoding an amino acid sequence of cytochrome
P450 showing activity of metabolizing a
protoporphyrinogen IX oxidase inhibitory-type herbicidal
compound has been introduced,
wherein said compound to be applied or added to said
area is a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound and selected from the group consisting
Of:
(1) flufenpyr-ethyl,
(2) 2-[4-chloro-2-fluoro
-5-(2-propynyloxy)pheny1)-4-methy-5-(trifluoromethyl)
-3(2H)-pyridazinone,
(3) carfentrazone-ethyl, and
3

CA 02504960 2005-05-16
( 4) sulfentrazone
(hereinafter, said method may be referred to the method
for selecting of the present Invention); and
2) a step of selecting a plant which has survived the
weed control effect of said applied or added compounds;
5. a method for controlling weeds comprising a step of applying
flufenpyr-ethyl to a cultivation area of a plant.
wherein to said plant, a DNA having a nucleotide sequence
encoding an amino acid sequence of cytochrome P450 showing
lo activity of metabolizing a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compound has been introduced;
6. a method for controlling weeds comprising a step of applying
2- [4-chloro-2-fluoro-5- ( 2-propynyloxy ) phenyl ] -4-methy-5- ( tr
ifluoromethyl) -3 ( 2H) -pyridazinone to a cultivation area of a
plant,
wherein to said plant, a DNA having a nucleotide sequence
encoding an amino acid sequence of cytochrome P450 showing
activity of metabolizing a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compound has been introduced;
7. a method for controlling weeds comprising a step of applying
carfentrazone-ethyl to a cultivation area of a plant,
wherein to said plant, a DNA having a nucleotide sequence
encoding an amino acid sequence of cytochrome P450 showing
activity of metabolizing a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compound has been introduced; and
4

CA 02504960 2013-01-30
8. a method for controlling weeds comprising a step of applying
sulfentrazone to a cultivation area of a plant,
wherein to said plant, a DNA having a nucleotide sequence
encoding an amino acid sequence of cytochrome P450 showing
activity of metabolizing a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compound has been introduced.
According to one aspect of the invention there is
provided a method for controlling weeds comprising a step
of applying at least one compound to a cultivation area of a
plant that comprises a heterologous DNA originally
introduced by transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence
that has 90% or more sequence identity to the amino acid
sequence of SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 2; and
wherein said at least one compound to be applied to
said area is a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound which is:
(1) flufenpyr-ethyl,
5

CA 02504960 2013-01-30
(2) 2-[4-chloro-2-fluoro-5-(2-
propynyloxy)pheny1]-4-methyl-5-(trifluoromethyl)-3(2H)-
pyridazinone,
(3) carfentrazone-ethyl, or
(4) sulfentrazone;
or any combination thereof.
According to a further aspect of the present invention
there is provided a method for selecting a herbicidal
compound resistant plant, said method comprising:
1) a step of applying or adding at least one
compound to a cultivation area or a culturing area of a
plant that comprises a heterologous DNA originally
introduced by transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence
that has 90% or more sequence identity to the amino acid
sequence of SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 2; and
5a

CA 02504960 2013-01-30
wherein said at least one compound to be applied or
added to said area is a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compounds which is:
(1) flufenpyr-ethyl,
(2) 2-[4-ch1oro-2-fluoro-5-(2-
propynyloxy)pheny1]-4-methy1-5-(trifluoromethyl)-3(2H)-
pyridazinone,
(3) carfentrazone-ethyl, or
(4) sulfentrazone;
or any combination thereof; and
2) a step of selecting a plant which has survived the
weed control effect of said applied or added at least one
compound.
According to another aspect of the invention there is
provided a method for controlling weeds comprising a step of
applying flufenpyr-ethyl to a cultivation area of a plant
that comprises a heterologous DNA introduced by
transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence
that has 90% or more sequence identity to the amino acid
sequence of SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 1, or
5b

CA 02504960 2012-06-14
(3) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 2.
According to yet another aspect of the invention there
is provided a method for controlling weeds comprising a step
of applying 2-[4-chloro-2-fluoro-5-(2-propynyloxy)pheny1]-4-
methy1-5-(trifluoromethyl)-3(2H)-pyridazinone to a
cultivation area of a plant that comprises a heterologous
DNA introduced by transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence
that has 90% or more sequence identity to the amino acid
sequence of SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 2.
According to still another aspect of the invention
there is provided a method for controlling weeds comprising
a step of applying carfentrazone-ethyl to a cultivation area
of a plant that comprises a heterologous DNA introduced by a
transformation,
5c

CA 02504960 2012-06-14
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence
that has 90% or more sequence identity to the amino acid
sequence of SEQ ID NO: 1 or 2,
(2) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 2.
According to a further aspect of the invention there
is provided a method for controlling weeds comprising a step
of applying sulfentrazone to a cultivation area of a plant
that comprises a heterologous DNA introduced by
transformation,
wherein said DNA has a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound, and
wherein said cytochrome P450 is:
(1) cytochrome P450 comprising an amino acid sequence
that has 90% or more sequence identity to the amino acid
sequence of SEQ ID NO: 1 or 2,
5d

CA 02504960 2012-06-14
(2) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 1, or
(3) cytochrome P450 comprising the amino acid
sequence of SEQ ID NO: 2.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows the restriction map of the plasmid
pBI-NdG6-rSt-1609soy.
Fig. 2 shows the restriction map of the plasmid
pBI-NdG6-rSt-1584soy.
Fig. 3 shows the photos of the wild-type line SR-1 and
the present plant (line 1609soy#17) grown for 14 days in a
greenhouse after spraying flufenpyr-ethyl (applied amount 1.78
mg/ 20 mL spray liquid).
Fig. 4 shows the restriction map of the plasmid
pBI-35S-rSt-1609soy.
Fig. 5 shows the photos of the wild-type line cv. Jack
and the present plant (the recombinant soybean line J18) grown
for 15 days in a greenhouse after spraying carfentrazone-ethyl
(applied amount 3.57 mg/20 mL spray liquid).
The abbreviations described in the above figures are
explained below.
5e

CA 02504960 2005-05-16
P450160990yDNA : the DNA encoding cytochrom P450 comprising
the amino acid sequence of SEQ ID NO: 1.
P450158490yDNA : the DNA encoding cytochrom P450 comprising
the amino acid sequence of SEQ ID NO: 2.
RuBPCOssCTP: the nucleotide sequence encoding the
chloroplast transit peptide of the small subunit of
ribulose-1,5-bisphosphate carboxylase of soybean (cv.
Jack).
CR16G6p: DNA in which the nucleotide sequence upstream of
restriction site of the restriction enzyme NdeI is removed
from the CR16G6 promoter.
CR16t : DNA in which the nucleotide sequence downstream of
restriction site of the restriction enzyme ScaI is removed
from the CR16 terminator.
N0Sp: promoter of the nopaline synthase gene.
NPTII: kanamycin resistance gene.
NOSt: terminator of nopaline synthase gene.
35Sp: 35S promoter of cauliflower mosaic virus.
GUS: 13-glucuronidase gene.
RB: the right border sequence of T-DNA.
LB: the left border sequence of T-DNA.
Co1E1 on: the replication origin of plasmid ColEl.
Ampr: the ampicillin resistance gene.
HindIII,EcoRI,BamHI,EcoT221,SacI, NotI: the cleavage sites
of the respective restriction enzyme.
6

CA 02504960 2005-05-16
DETAILED DESCRIPTION OF THE PREFERRED EXAMPLES
Hereinafter, the present invention will be described in
detail.
The "protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound" of "cytochrome P450 showing activity of
metabolizing a protoporphyrinogen IX oxidase inhibitory-type
herbicidal compound" used in the present invention, is a
herbicidal compound which is contained as an active ingredient
in a composition for weed control and inhibits porphyrin
biosynthesis. As the compounds inhibiting porphyrin
biosynthesis, for example, there are compounds inhibiting
activity of protoporphyrinogen IX oxidase (EC 1.13.11.27,
hereinaftermaybereferredtoasPPO)andthelike. Specifically
for example, as the compounds inhibiting activity of PPO , there
are the compounds disclosed in Duke, SO., Rebeiz, C.A. ACS
Symposium Series 559, Porphyric Pesticides, Chemistry,
Toxicology, and Pharmaceutical Applications. American Chemical
Society, Washington DC (1994) and the like. In such herbicidal
compounds, various molecular species having different
structures are contained (Duke et al., Weed Sci. 39: p465 (1991);
Nandihalli et al., Pesticide Biochem. Physiol. 43: p193 (1992) ;
Matringe et al., FEES Lett. 245: p35 (1989); Yanase, Andoh,
Pesticide Biochem. Physiol. 35: p70 (1989)), there maybe. for
example,
7

CA 02504960 2005-05-16
diphenylether :
for instance, chloromethoxynil, biphenox,
chloronitrophene (CNP), acifluorfen (i.e.
5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid
and the like) and it's ethyl ester, acifluorfen-sodium,
oxyfluorfen (i.e. 2-chloro-1-(3-ethoxy-4-nitrophenoxy)
-4-trifluoromethylbenzene), or oxadiazol (for instance,
oxadiazon (i.e. 3-(2,4-dichloro-5-(1-methylethoxy)phenyl]
-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one) and the
like);
cyclic imide :
for instance, S-23142 (i.e.
N-(4-chloro-2-fluoro-5-propargyloxypheny1)-3,4,5,6-tetrahyd
rophtalimide and the like), or chlorphthalim (i.e.
N-(4-chloropheny1)-3,4,5,6-tetrahydrophtalimide);
phenylpyrazole :
for instance, TNPP-ethyl (i.e. ethyl
2-[1-(2,3,4-trichloropheny1)-4-nitropyrazoly1-5-oxy]propion
ate) and the like;
pyridine derivatives :
for instance, LS82-556 (i.e.
N3 - ( 1 -phenylethyl ) -2 , 6 -dimethyl- 5 -propyonylnicotinamide )
and the like;
phenopylate, o-phenylpyrrolidinocarbamate analog of
phenopylate, or piperidinocarbamate analog of phenopylate and
8

CA 02504960 2005-05-16
the like.
As said herbicidal compounds, there may be, specifically
for example, a compound of the following formula (I):
0 ,CH3
G-N>
(I)
0
wherein in formula (I) G represents a group shown in any one
of the following G-1 to G-9:
9

CA 02504960 2005-05-16
R4 R5
R3 5-1R3
RI
G-1 G-2 G-3
Fc
0 _
R5 <R4
1110 X II 0
R5
R1 RI R'
G-4 G-5 G-6
R s.
0 ¨S\
R3 R3
R7
G-7 G-8 G-9
wherein in G-1 to G-9,.
X represents an oxygen atom or sulfur atom;
Y represents an oxygen atom or sulfur atom;
RI represents a hydrogen atom or halogen atom;
R2 represents a hydrogen atom, C1-C8 alkyl group. C1-C8

CA 02504960 2005-05-16
haloalkyl group, halogen atom, hydroxyl group, -0R9 group, -SH
group, -S ( 0 )pR9 group, -COR9 group, -0O2R9 group, -C ( 0) SR9 group,
-C ( 0 )NR11R12 group, -CONH2 group, -CHO group, -CR9=NOR16 group,
-CHP.CR19CO2R9 group, -CH2CHR19CO2R9 group, -CO2N=CR13R14 group,
nitro group, cyano group, -NHS021215 group, -NHSO2NHR15 group,
-NR9R29 group, -NH2 group or phenyl group that may be substituted
with one or more Ci-C4 alkyl groups which may be the same or
different;
p represents 0, 1 or 2;
R3 represents C1-C2 alkyl group, C1-C2 haloalkyl group,
-OCH3 group, -SCH3 group, -OCHF2 group, halogen atom, cyano group,
nitro group or C1-C3 alkoxy group substituted with a phenyl group
which may be substituted on the ring with at least one substituent
selected from a halogen atom, C1-C3 alkyl group, C1-C3 haloalkyl
group, OR" group, NR111229 group, SR" group, cyano group, CO2R29
group and nitro group;
R4 represents a hydrogen atom, C1-C3 alkyl group or C1-C3
haloalkyl group;
R5 represents a hydrogen atom, C1-C3 alkyl group, C1-C3
haloalkyl group, cyclopropyl group, vinyl group, C2 alkynyl group,
cyano group, -C ( 0 )R29 group, -0O21229 group, -C (0 )NR29R21 group,
--
CHR16R17CN group, - CR161217C (0) R" group,
-C16R17CO2R29 group, -CR16It's17L;( 0)NR20R21 group, -CHR160H group,
-CHR160C(0)R2 group or -OCHR160C ( 0)NR20It".21 group, or, when G
represents G-2 or G-6, R4 and R5 may represent C=0 group together
11

CA 02504960 2005-05-16
with the carbon atom to which they are attached;
R6 represents C1-C6 alkyl group, C1-C6 haloalkyl group,
C2-C6alkoxyalkylgroup,C3-CealkenylgrouporC3-C6alkynylgroup;
R7 represents a hydrogen atom, C1-05 alkyl group, C1-C6
haloalkyl group, halogen atom, -5(0)2(C1-C6 alkyl) group or
-C(=0)R22 group;
R6 represents a hydrogen atom, C1-C8 alkyl group, C3-C8
cycloalkyl group, C3-C alkenyl group, C3-C8 alkynyl group, Cl-Ca
haloalkyl group, C2-C8 alkoxyalkyl group, C3-05
alkoxyalkoxyalkyl group, C3-C8 haloalkynyl group, C3-C8
haloalkenyl group, Cl-Cs alkylsulfony1 group, Cl-Ca
haloalkylsulfonyl group, C3-C8 alkoxycarbonylalkyl group,
-S(0)2NH(C1-Ce alkyl) group, -C(0)R23 group or benzyl group which
may be substituted with R24 on the phenyl ring;
R9 represents C1-C8 alkyl group, C3-05 cycloalkyl group,
C3-C8 alkenyl group, C3-C8 alkynyl group, C1-C8 haloalkyl group,
C2-Ce alkoxyalkyl group, C2-C8 alkylthioalkyl group, C2-C8
alkylsulfinylalkyl group, C2-C8 alkylsulfonylalkyl group, C4-C8
alkoxyalkoxyalkyl group, C4-C8 cycloalkylalkyl group, C4-C8
cycloalkoxyalkyl group, C4-05 alkenyloxyalkyl group, C4-C8
alkynyloxyalkyl group, C3-C8 haloalkoxyalkyl group, C4-C8
haloalkenyloxyalkyl group, C4-CB haloalkynyloxyalkyl group,
C4-C8 cycloalkylthioalkyl group, C4-05 alkenylthioalkyl group,
C4-C8 alkynylthioalkyl group, C1-C4 alkyl group substituted with
a phenoxy group which may be substituted on the ring with at
12

CA 02504960 2005-05-16
least one substituent selected from a halogen atom. C1-C3 alkyl
group and C1-C3 haloalkyl group, C1-C4 alkyl group substituted
with a benzyloxy group which may be substituted on the ring with
at least one substituent selected from a halogen atom, C1-C3
alkyl group and C1-C3 haloalkyl group, C4-C8 trialkylsilylalkyl
group, C2-C8 cyanoalkyl group, C3-C8 halocycloalkyl group, C3-C8
haloalkenyl group, C5-C8 alkoxyalkenyl group, C5 -Ca
haloalkoxyalkenyl group. C5-C8 alkylthioalkenyl group, C3-C8
haloalkynyl group, C5-C8 alkoxyalkynyl group, C5-C8
haloalkoxyalkynyl group, C5-C8 alkylthioalkynyl group, C2-Ce
alkylcarbonyl group, benzyl group which may be substituted on
the ring with at least one substituent selected from a halogen
atom, C1 -C3 alkyl group, C1 -C3 haloalkyl group, -0R28 group, -NR11R28
group, -SR28 group, cyano group, -0O2R28 group and nitro group,
-CRI6R17C0R1 group, -CR16R17CO2R2 group.
-CR"R17P (0)(--ux10
)2 group, -CR16R17P(S) (OR1 ) 2 group,
-CR16R17C(0)NR11K".1.2 group,
-CR16R17C(0)NH2 group, -C(=CR26R27)COR1 group, -C(=CR26R27)CO2R2
group,
=u26-27
)P(0)(0R1 )2 group, -C(=CR26R27)P(S)(0R1 )2 group,
_c( =cR26-27
x )C(0)NR11R12 group, -C(=CR26R27)C(0)NH2 group, or any
one of rings shown in Q-1 to Q-7:
yi
1101
Q-1 Q-2 Q4 Q-5 Q-6 Q-7
13

CA 02504960 2005-05-16
which may be substituted on the ring with at least one substituent
selected from a halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl
group, C2-C6 alkenyl group, C2-C6 haloalkenyl group, C2-C6 alkynyl
group, C3-C6 haloalkynyl group, C2-C6 alkoxyalkyl group, -0R28
group, -SR28 group, -NR11K...213 group, C3-C8 alkoxycarbonylalkyl
group, C2-C4 carboxyalkyl group, -0O2R28 group and cyano group;
R1 represents a C1-C6 alkyl group, C2-C6 alkenyl group,
C3-C6 alkynyl group or tetrahydrofuranyl group;
R11 and R13 independently represent a hydrogen atom or C1-C4
alkyl group;
+,12
it represents C1-C6 alkyl group. C3-C6 cycloalkyl group,
C3-C6 alkenyl group, C3-C6 alkynyl group, C2-C6 alkoxyalkyl group,
C1-C6 haloalkyl group. C3-C6 haloalkenyl group, C3-C6 haloalkynyl
group, phenyl group which may be substituted on the ring with
at least one substituent selected from a halogen atom, C1-C4
alkyl group and C1-C4 alkoxy group or -CR16R17CO2R25 group; or,
R11 and R12 together may represent - (CH2)5- , - (CH2)4- or
-CH2CH2OCH2CH2- , or in that case the resulting ring may be
substituted with a substituent selected from a C1-C3 alkyl group,
a phenyl group and benzyl group;
-14
X represents a C1-C4 alkyl group or phenyl group which
may be substituted on the ring with a substituent selected from
a halogen atom, C1-C3 alkyl group and C1-C3 haloalkyl group; or,
R13 and R." may represent C3-C8 cycloalkyl group together
with the carbon atom to which they are attached;
14

CA 02504960 2005-05-16
RIS represents Ci-C4 alkyl group, C1-C4 haloalkyl group or
C3-C6 alkenyl group;
R" and 1237 independently represent a hydrogen atom or C1-C4
alkyl group, C1-C4 haloalkyl group, Cz-C4 alkenyl group. C2-C4
haloalkenyl group, C2-C4 alkynyl group. C3-C4 haloalkynyl group;
Or,
123-6 and It" may represent C3-C6 cycloalkyl group with the
carbon atom to which they are attached, or the ring thus formed
may be substituted with at least one substituent selected from
a halogen atom, a C1-C3 alkyl group and C1-C3 haloalkyl group;
-18
E. represents a hydrogen atom, C1-C6 alkyl group, C3-C6
alkenyl group or C3-C6 alkynyl group;
R" represents a hydrogen atom, C1-C4 alkyl group or halogen
atom,
R2 represents a hydrogen atom, C1-C6 alkyl group,. C3-C6
cycloalkyl group, C3 -C6 alkenyl group, C3 -C6 alkynyl group, C2 -C6
alkoxyalkyl group, C1-C6 haloalkyl group. C3-C6 haloalkenyl group.
C3-C6 haloalkynyl group, phenyl group which may be substituted
on the ring with at least one substituent selected from a halogen
atom, C1-C4 alkyl group and -OR or _cRi6R"co2R25
" group,
group;
Rn represents a hydrogen atom, C1-C2 alkyl group or
-0O2(CI-Ca alkyl) group;
R22 represents a hydrogen atom, C1-C6 alkyl group, C1-C6
alkoxy group or NH(C1-C6 alkyl) group;
R23 represents C1-C6 alkyl group, C1-C6 haloalkyl group,

CA 02504960 2005-05-16
C1-C6 alkoxy group, NH( C1-C6 alkyl) group, benzyl group, C2-C8
dialkylamino group or phenyl. group which may be substituted with
R24;
R24 represents C1-C6 alkyl group, 1 to 2 halogen atoms,
Cl-C6 alkoxy group or CF3 group;
R25 represents C1-C6 alkyl group, C1-C6 haloalkyl group,
C3-C6 alkenyl group. C3-C6 haloalkenyl group, C3-C6 alkynyl group
or C3-C6 haloalkynyl group;
R26 and R27 each represent independently a hydrogen atom,
C3.-c4 alkyl group. C1-C4 haloalkyl group, C2-C4 alkenyl group,
C2-C4 haloalkenyl group. C2-C4 alkynyl group, C3-C4 haloalkynyl
group, -OR" group, -NHR28 group, or .SR28 group; or,
R28 and R27 may represent C3-C8 cycloalkyl group with the
carbon atom to which they are attached, or each of the ring thus
formed may be substituted with at least one substituent selected
from a halogen atom, C1-C3 alkyl group and C1-C3 haloalkyl group;
and,
R28 represents a hydrogen atom, C1-C6 alkyl group, C1-C6
haloalkyl group, C3-C6 alkenyl group, C3-C6 haloalkenyl group,
C3-C6 alkynyl group, C3-C6 haloalkynyl group, C2-C4 carboxyalkyl
group, C3-C8 alkoxycarbonylalkyl group, C3-C8
haloalkoxycarbonylalkyl group, C5-C9 alkenyloxycabonylalkyl
group, C8-C8 haloalkenyloxycabonylalkyl group. C8-C8
alkynyloxycabonylalkyl group, C5-C9
haloalkynyloxycabonylalkyl group, C5 - C9
16

CA 02504960 2005-05-16
cycloalkoxycabonylalkyl group or C5-C9
halocycloalkoxycabonylalkyl group.
And further, there may be, specifically for example, a
compound having the following formula (hereinafter, may be
referred to as the compound (II)):
F 0 CH3
CI N
0 0
,-COOCH3
, butafenacil, flufenpyr-ethyl,
methyl 2-[2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo
-4-(trifluoromethyl)-1(2H)-pyrimidiny11-4-fluorophenoxy]phe
noxyacetate,
ethyl [3-[2-chloro-5-0,6-dihydro-3-methy1-2,6-dioxo
-4-(trifluoromethyl)-1(2H)-2-pyrimiziny1]-4-fluorophenoxy]-
2-pyridazinyl]oxyacetate,
2-[4-chloro-2-fluoro-5-(2-propynyloxy)pheny1]-4-methy
-5-(trifluoromethyl)-3(2H)-pyridazinone,
carfentrazone-ethyl, sulfentrazone and the like.
In the method for controlling weeds of the present
invention, the compound to be applied to a cultivation area of
the present plant is a protoporphyrinogen IX oxidase
inhibitory-type herbicidal compound and selected from the group
17

CA 02504960 2005-05-16
consisting of:
(1) flufenpyr-ethyl,
(2) 2-[4-chloro-2-fluoro-5-(2-propynyloxy)phenyl]
-4-methy-5-(trifluoromethyl)-3(2H)-pyridazinone,
(3) carfentrazone-ethyl, and
(4) sulfentrazone.
Here, "flufenpyr-ethyl" is the compound of CAS registry
no. 188489-07-8, "carfentrazone-ethyl" is the compound of CAS
registry no. 128639-02-1, "sulfentrazone" is the compound of
io CAS registry no. 122836-35-5. Hereinafter,
2-(4-chloro-2-fluoro-5-(2-propynyloxy)pheny1]-4-methy-5-(tr
ifluoromethyl)-3(2H)-pyridazinone (CAS registry no.
186489-06-7) may be referred to as the compound (I).
When said herbicidal compounds are applied to the
cultivation area of the present plant, insecticidal compounds,
fungicidal compounds, plant growth regulatory compounds,
fertilizer ingredients and the like may also be applied as needed
along with said herbicidal compound.
In the present invention, "sequence homology" refers to
the homology between two nucleotide sequences or two amino acid
sequences. Such "sequence homology" may be determined by
comparing the two sequences, each aligned in an optimal state,
over the whole region of the test sequences. As such, additions
or deletions (for example, gaps) can be utilized in the optimal
18

CA 02504960 2012-06-14
=
alignment of the test nucleic acid sequences or amino acid
sequences. Such sequence homology can be calculated through
the step of producing the alignment conducted by a homology
analysis using a program such as PASTA (Pearson & Lipman, Proc.
Natl. Acad. Sci. USA, 4, 2444-2448 (1988)). BLAST (Altschul et
al. Journal of Molecular Biology, 215, 403-410 (1990)),CLUSTAL
W (Thompson, Higgins & Gibson, Nucleic Acid Research, 22,
4673-4680 (1994a) ) and the like. Such programs, for example,
can be typically utilized on a webpage of the DNA Data
Bank of Japan (the international databank operated
within the Center for Information Biology and DNA Data
Bank of Japan). Further, the sequence homology may be
determined by utilizing a commercially available
sequence analysis software. Specifically for example,
it can be calculated by producing an alignment conducted by a
homology analysis by the Lipman-Pearson method (Lipman. D.J.
and Pearson, W.R., Science, 227, 1435-1441, (1985)) utilizing
GENETYX-WIN Ver. . 6 (manufactured by GENETYX Corporation) . For
example, as the results of alignment at homology analysis of
the amino acid sequence of SEQ ID NO: 1 and the amino acid sequence
of SEQ ID NO: 2 by using the method, it is calculated 90% of
sequence homology.
Cytochrome P450 used in the present invention is a family
of proteins containing protoheme and named for its spectroscopic
19

CA 02504960 2005-05-16
property indicating Soret near 450 nm when it binds with carbon
monoxide at a reduction state. The cytochrome P450 exists in
various animal tissues, plant tissues, fungi, yeast and bacteria .
The cytochrome p450 has abilities to catalyze, with free oxygen
and 2 electrons generally derived from NADPH, or rarely derived
from NADH, monooxygenation of the present herbicidal compounds
and the like and subsequent elimination of functional groups.
The cytochrome p450 may be (1) a type to be provided electron
from the electron transfer system with both of ferredoxin and
NADPH-ferredoxin reductase, or (2) a type to be provided electron
directly from NADPH-cytochrome P450 reductase. Preferably, it
may be the former. The cytochrome P450 in the former may be
located in any one of subcellular organelles of a host cell or
in the cytoplasm. The ferredoxin may be an endogenous ferredoxin
in the host cell or a foreign ferredoxin produced in the host
cell wherein a foreign ferredoxin gene has been introduced into
the host cell.
Preferable cytochrome P450 used in the present invention
may be cytochrome P450 derived from actinomyces. Here,
"actinomyces" is a family of prokaryote belonging to the
Actinomycetales, which are a family of Grain-positive bacteria
to be grouped 8 genera of Streptomyces, Actinomyces ,
Mycobacterium, Frankia, Nocardia and the like .= More preferable
cytochrome P450 may be cytochrome P450 derived from actinomyces

CA 02504960 2005-05-16
belonging to Streptomyces, concretely, for example, cytochrome
P450 derived from Streptomyces phaeochromogenes, Streptomyces
testaceus, Streptomyces achromogenes, Streptomyces
griseofuscus, Streptomyces thermocoerulescens, Streptomyces
nogalater, Streptomyces tsusimaensis, Streptomyces
glomerochromogenes, Streptomyces olivochromogenes,
Streptomyces ornatus, Streptomyces griseus, Streptomyces
lanatus, Streptomyces misawanensis, Streptomyces pallidus,
Streptomyces roseorubens, Streptomyces rutgersensis,
Streptomyces steffisburgensis, Saccharopolyspora taberi and
the like. Concrete examples of cytochrome P450 derived from
actinomyces beonging to Streptomyces may be cytochrome P450
having the amino acid sequence of SEQ ID NO: 1, cytochrome P450
having the amino acid sequence of SEQ ID NO: 2, cytochrome P450
having an amino acid sequence having 90% or more sequence homology
with the amino acid sequence of SEQ ID NO: 1 or 2, and the like.
The gene (DNA) having a nucleotide sequence encoding an
amino acid sequence of cytochrome P450 may be a cytochrome P450
gene having naturally-occurring nucleotide sequence, and a gene
having a nucleotide sequence encoding cytochrome P450 in which
the codon usage has been optimized for its expression in the
host cell. Also, it may be a gene encoding a protein having
cytochrome P450 activity wherein substitution, addition,
deletion or the like of amino acid has been introduced to an
21

CA 02504960 2005-05-16
amino acid sequence of a naturally-occurring cytochrome P450,
and a gene encoding a protein selected based on the cytochrome
P450 activity. Concretely, the gene encoding cytochrome P450
may be a gene encoding cytochrome P450 described in International
Patent Publication WO 03040370.
The gene having a nucleotide sequence encoding an amino
acid sequence of the cytochrome P450 introduced to the host cell
may be located in any one of subcellular organelles in the cell
or in chromosome in nuclear. Also, the cytochrome P450 may be
located in any one of subcellular organelles, cytoplasm or
extracellular space, preferably subcellular organelles, more
preferably plastid.
For the transition of cytochrome P450 to subcellular
organelles in the cell, it may be introduced to the host cell
a chimeric DNA in which a DNA having a nucleotide sequence encoding
organelles transit peptide sequence is linked in frame upstream
of a DNA having a nucleotide sequence encoding an amino acid
sequence of cytochrome P450. Here, " linked in frame" means
that the reading frame of the nucleotide sequence encoding the
organelles transit peptide sequence and the reading frame of
the nucleotide sequence encoding the amino acid sequence of the
cytochrome P450 are linked to form one continuous reading frame.
The transit peptide sequence to transit and localize the protein
22

CA 02504960 2005-05-16
to subcellular organelles in the host cell is, for example, a
transit peptide sequence of a cytoplasmic precursor of a
chloroplast protein of a plant described in USP5717084, and 'a
chimeric sequence comprising plural kinds of transit peptide
sequences described in USRE36449 etc. Concretely, it is, for
. example, chloroplast transit peptide sequence derived from
ribulose-1,5-bisphosphate carboxylase (hereinafter, may be
referred to as RuBPC0) small subunit of soybean which is
obtainable by a method described in International Patent
lo Publication W003040370.
Asthemethodofartificiallycausingdeletions, additions
or substitutions of amino acid residues in an amino acid sequence
of the cytochrome P450 described above, for example, there is
a method comprising a steps of carrying out site-directed
mutagenesis on a DNA having a nucleotide sequence encoding the
amino acid sequence, and then allowing the expression of such
DNA by a conventional method. Concretely, for example, it may
be a method utilizes amber mutations (gapped duplex method,
Nucleic Acids Res., 12, 9441-9456 (1984)), a method by PCR
utilizing primers for introducing amutation and the like . Also,
for example, it may be a method comprising the steps of carrying
out random mutagenesis on a DNA having a nucleotide sequence
encoding the amino acid sequence and the like. Concretely, for
example, it may be a method of conducting PCR by utilizing the
23

CA 02504960 2005-05-16
DNA having a nucleotide sequence encoding the amino acid sequence
as a template and a primer pair which can amplify the full length
of the DNA, under the conditions in which concentration of each
of dATP, dTTP, dGTP and dCTP utilized as a substrate are changed,
or, under the conditions in which the concentration of Mg2+ is
made increase more to promote the polymerase reaction, and the
like. Such methods of PCR may be, for example, the conventional
methods described in Method in Molecular Biology, (31). 1994,
97-112 and the like.
In the method for confirming cytochrome P450 activity of
the protein to which mutation has been introduced as described
above, for example, the DNA having a nucleotide sequence encoding
the amino acid sequence of the protein to which the mutation
has been introduced is inserted to a vector plasmid firstly.
The vector plasmid is introduced in a host cell to express the
DNA, as described in W003040370 and the like . Thus, such activity
may be confirmed by adding and reacting the present herbicidal
compound as a substrate, ferredoxin and NADPH-ferredoxin
reductase to an extract of the host cell in which mutated
cytochrome P450 was produced, and measuring the decreased
substrate in the reaction mixture after the reaction.
The DNA having a nucleotide sequence encoding an amino
acid sequence wherein substitution, addition, deletion or the
24

CA 02504960 2005-05-16
like of amino acid has been introduced to the particular amino
acid sequence of cytochrome P450 can be obtained from various
DNA libraries, by utilizing a polynucleotide having a nucleotide
sequence complementary to the nucleotide sequence encoding the
particular amino acid sequences described above as a probe and
carrying out hybridization under stringent conditions according
to the conventional genetic engineering methods. Also, the DNA
having a nucleotide sequence encoding an amino acid sequence
having 90% or more sequence homology to the particular amino
acid sequences, concretely, for example, a DNA having a
nucleotide sequence encoding cytochrome P450 having an amino
acid sequence having 90% or more sequence homology to the amino
acid sequence of SEQ ID NO: 1 or 2 can be obtained from various
DNA libraries, by utilizing a polynucleotide having a nucleotide
sequence complementary to the nucleotide sequence encoding the
particular amino acid sequence as a probe and carrying out
hybridization under stringent conditions according to the
conventional genetic engineering methods. As the "stringent
conditions", there can be mentioned, for example, the conditions
under which hybridization is performed at 68 C in a solution
containing 6xSSC (let the solution containing 3 M NaC1 and 0.3
M trisodium citrate be 20 xSSC ) and then the hybridized membrane
is washed at 68 C with 0.1xSSC and 0.5% SDS in a hybridization
conducted according to the conventional method described in such
as Sambrook, J., Frisch, E. F = , and Maniatis, T.; chapter 9.53,

CA 02504960 2005-05-16
Molecular Cloning 2nd edition, Cold Spring Harbor Press(1989) .
The salt concentration in the washing step can be selected, for
example, from the conditions of 2 x SSC ( low stringency condition)
to the conditions of 0.1 x SSC (high stringency condition) . A
temperature in the washing step can be selected, for example,
from room temperature (low stringency condition) to 68 C (high
stringency condition) . Alternatively, both of the salt
concentration and temperature may be changed.
lo To
introduce to plant and express the gene to be introduced
in the present invention, generally, a DNA having a nucleotide
sequence encoding the amino acid sequence of the protein to be
expressed, a DNA in which aforementioned DNA and a promoter
functional in the plant cell is operably linked or the like,
may be inserted to a vector plasmid functional in the plant cell,
and introduced to the plant cell. When the vector plasmid already
possessing the promoter functional in the plant cell is utilized,
aforementioned DNA may be inserted downstream of the promoter
present in the vector plasmid so that the promoter and the DNA
having a nucleotide sequence encoding the amino acid sequence
of the protein to be expressed are operably linked.
Here, the promoter functional in the host cell such as
plant cell is a nucleotide sequence which is connected 5' upstream
of a nucleotide sequence of a gene having a nucleotide sequence
26

CA 02504960 2005-05-16
encoding an amino acid sequence of a protein ( the structural
gene) and has a function to control initiation of the
transcription of the gene in the host cell such as plant cell.
As the functional promoter in the plant cell, for example, there
is mentioned T-DNA derived constitutive promoters such as
nopaline synthase gene promoter and octopine synthase gene
promoter; plant virus-derived promoters such as cauliflower
mosaic virus derived 19S and 35S promoters; inducible promoters
such as phenylalanine arnmonia-lyase gene promoter, chalcone
synthase gene promoter and pathogenesis-related protein gene
promoter; the plant promoter described in International Patent
Publication W02000020613, and the like. Also, a terminator
functional in the host cell such as plant cell may be linked
downstream of a DNA in which the promoter functional in the host
cell such as plant cell described above and a DNA having a
nucleotide sequence encoding an amino acid sequence of the
protein showing PPO activity or the cytochrome P450 are operably
linked.
The terminator functional in the host cell such as plant
cell is a nucleotide sequence which is connected 3' downstream
of a nucleotide sequence of a gene having a nucleotide sequence
encoding an amino acid sequence of a protein (the structural
gene) and has a function to add polyadenine sequence for
stabilization of the transcription of the gene. As the
27

CA 02504960 2005-05-16
functional terminator in the plant cell, for example, there is
mentioned T-DNA derived constitutive terminators such as
nopaline synthase gene (NOS) terminator; plant virus derived
terminators such as terminators of garlic virus GV1 or GV2; the
plant terminator described in International Patent Publication
W02000020613; and the like.
As the plant cell to be utilized as the host cell, there
are, for example, plant cells derived from dicotyledonous plant,
including solanaceous plant such as eggplant, potato and tomato;
cruciferous plant such as rape, canola, lettuce, sugar beet and
arabidopsis; leguminous plant such as soybean, pea and alfalfa;
rosaceous plant such as apple, pear and almond; citrus such as
orange and lemon; cotton, linum, sunflower, banana, grape, almond,
poplar, and plant cells derived from monocotyledonous plant
including poaceous plant such as corn, rice, wheat, barley, rye,
oat and sorghum and the like.
As the plant cell to be utilized as the host cell, there
are various plant cells such as plant tissues, plant bodies,
cultured cells, seeds and the like.
As the method for introducing into a host cell such as
a plant cell DNA having the structural gene to which a promoter
and a terminator functional in the host cell such as the plant
cell are linked, there are, for example, a method by infection
28

CA 02504960 2005-05-16
with agrobacterium (Japanese examined patent publication No.
He12-58917 and Japanese unexamined patent publication No.
Syo-60-70080) , electroporation into protoplast (Japanese
unexamined patent publication No. Syo-60-251887 and Japanese
unexamined patent publication No. Hei5-68575) , particle gun
methods ( Japanese unexamined patent publication No. He15-508316
and Japanese unexamined patent publication No. Syo-63-258525)
or the like.
In such case, the transformant to which the DNA has been
introduced can be selected based on phenotype of a selective
marker gene, by simultaneously introducing a selective marker
gene selected from hygromycin phosphotransferase gene, neomycin
phosphotransferase gene, chloramphenicol acetyltransferase
gene and the like, and a DNA having a nucleotide sequence encoding
an amino acid sequence of the cytochrome P450 showing the
protoporphyrinogen IX oxidase inhibitory-type herbicidal
compound metabolizing activity. The selective marker gene and
the DNA having a nucleotide sequence encoding an amino acid
sequence of the cytochrome P450 showing the protoporphyrinogen
IX oxidase inhibitory-type herbicidal compound metabolizing
activity may be tandemly inserted into the same vector and
introduced. A vector plasmid comprising the selective marker
gene and the DNA having a nucleotide sequence encoding an amino
acid sequence of the cytochrome P450 showing the
29

CA 02504960 2005-05-16
protoporphyrinogen IX oxidase inhibitory-type herbicidal
compound metabolizing activity (the present DNA) may be
introduced simultaneously. A transformant to which the
objective gene has been introduced may also be selected by
culturing with a medium containing the protoporphyrinogen IX
oxidase inhibitory-type herbicidal compound, plant cells to
which a vector comprising the objective gene has been introduced
and isolating grown clones.
The presence of the present DNA in the transformant may
be confirmed by preparing DNA from the transformant and then
conducting with the prepared DNA genetic engineering analysis
methods ( such as confirming restriction enzyme sites, analysis
of nucleotide sequence, southernhybridization,PCRandthelike)
described in, for example, "Molecular Cloning: A Laboratory
Manual 2m1 edition" (1989), Cold Spring Harbor Laboratory Press
and the like.
Specifically, for example, rice or Arabidopsis having
introduced therein the present DNA can be obtained according
to the method described inModel-Shokubutu-No-Jikken-Protocol:
me, Shiroinunazuna-Hen (Supervisors: Koh SHIMAMOTO and
Kiyotaka OKADA, Shujun-sha, 1996), Fourth chapter. Further,
there can be obtained a soybean having introduced therein the
present DNA by an introduction into a soybean somatic embryo

CA 02504960 2005-05-16
with a particle gun according to the method described in Japanese
Unexamined Patent Publication No. 3-291501. Likewise, a maize
having introduced therein the present DNA can be obtained by
an introduction into maize somatic embryo with a particle gun
according to the method described by Fromm, M.E. , et al.,
310/Technology, 8; p 838 (1990) . Wheat having introduced
therein the present DNA can be obtained by introducing the DNA
into aseptically-cultured immature embryo with a particle gun
according to a conventional method described by TAKUMI et al.,
Journal of Breeding Society (1995). 44: Extra Vol. 1, p 57.
Likewise, barley having introduced therein the present DNA can
be obtained by an introduction into aseptically-cultured barley
immature embryo with a particle gun according to a conventional
method described by HAGIO, et al., Journal of Breeding Society
(1995), 44; Extra Vol. 1, p 67.
From thus produced transformant, a transgenic plant to
which the present DNA have been introduced can be obtained, by
regenerating a plant body according to the method for culturing
the plant cell described in, for example,
"Shokubutu-Saibou-Soshiki-Baiyo, Jissai, Ouyou, Tenbou",
Harada, Komamine Ed., Rikogakusha (1979) , p65-118 and the like.
Further, by crossing of the transgenic plant having
introduced and expressed therein the present DNA and a plant
31

CA 02504960 2005-05-16
of the targeted variety, the present DNA can be introduced to
a chromosome of the plant of the targeted variety, and the plant
of the targeted variety to which the present DNA has been
introduced can be obtained.
Specifically, for example, to produce a recombinant
soybean line to which a DNA having a nucleotide sequence encoding
the amino acid sequence of SEQ ID NO: 1 has been introduced,
the DNA is introduced to somatic embryos of soybean by using
a particle gun according to the method described in Japanese
unexamined patent publication No. Hei3-291501. Next, for
investigating the resistance of the obtained recombinant soybean
line to the present herbicidal compound, it may be carried out
scoring evaluation as to sensitivity in a spray test of the present
herbicidal compound according to the method described below in
Example 5 and the like (evaluation by scoring index based on
the degree of phytotoxicity as dying of the individual and
browning or whitening of the leaves or stems caused by compound
spraying) .
. Also, concretely, for example, to produce a recombinant
corn line to which a DNA having a nucleotide sequence encoding
the amino acid sequence of SEQ ID NO: 1 has been introduced,
the DNA is introduced to somatic embryos of corn byusing a particle
gun according to the method described in Fromm, M. E. , et al..
32

CA 02504960 2005-05-16
Bio/Technology, 8; p838 (1990) . Next, for investigating the
resistance of the obtained recombinant corn line to the present
herbicidal compound, it may be carried out scoring evaluation
as to sensitivity in a spray test of the present herbicidal
compound according to the method described below in Example 5
and the like (evaluation by scoring index based on the degree
of phytotoxicity as dying of the individual and browning or
whitening of the leaves or stems caused by compound spraying) .
Also, concretely, for example, to produce a recombinant
cotton line to which a DNA having a nucleotide sequence encoding
the amino acid sequence of SEQ ID NO: 1 has been introduced,
the DNA is introduced to cotton according to Agrobacterium
infection method. Next, for investigating the resistance of
the obtained recombinant cotton line to the present herbicidal
compound, it may be carried out scoring evaluation as to
sensitivity in a spray test of the present herbicidal compound
according to the method described below in Example 5 and the
like (evaluation by scoring index based on the degree of
phytotoxicity as dying of the individual and browning or
whitening of the leaves or stems caused by compound spraying) .
Also, concretely, for example, to produce a recombinant
rape line to which a DNA having a nucleotide sequence encoding
the amino acid sequence of SEQ ID NO: 1 has been introduced,
33

CA 02504960 2005-05-16
the DNA is introduced to rape according to Agrobacterium
infection method. Next, for investigating the resistance of
the obtained recombinant rape line to the present herbicidal
compound, it may be carried out scoring evaluation as to
sensitivity in a spray test of the present herbicidal compound
according to the method described below in Example 5 and the
like (evaluation by scoring index based on the degree of
phytotoxicity as dying of the individual and browning or
whitening of the leaves or stems caused by compound spraying) .
Also, concretely, for example, to produce a recombinant
wheat line to which a DNA having a nucleotide sequence encoding
the amino acid sequence of SEQ ID NO: 1 has been introduced,
the DNA is introduced to calli derived from immature embryo of
wheat by using a particle gun according to the method described
in TAKUMI et al., Journal of Breeding Society (1995) , 44: Extra
Vol. 1, p 57. Next, for investigating the resistance of the
obtained recombinant wheat line to the present herbicidal
compound, it may be carried out scoring evaluation as to
sensitivity in a spray test of the present herbicidal compound
according to the method described below in Example 5 and the
like (evaluation by scoring index based on the degree of
phytotoxicity as dying of the individual and browning or
whitening of the leaves or stems caused by compound spraying).
34

CA 02504960 2005-05-16
In the method for controlling weeds of the present
invention, aneffectiveamount of the present herbicidal compound
is applied to the cultivation area of the present plant. The
amount of the application of the present herbicidal compound
may be appropriately decided according to season of the
application, variety of the weed, kind of the present herbicidal
compound and the like.
Because degree of phytotoxicity of the present plant is
highly reduced in applying the present herbicidal compound, the
present plant can be grown well when the present herbicidal
compound is sprayed or added to the area growing or culturing
thepresentplant. Bycultivatingthepresentplantandapplying
a weed controlling agent containing the present herbicidal
compound as an active ingredient to the cultivation area of the
plant, it can be to remove efficiently plants such as weeds except
for the present plant, then to improve the yield and quality
of the present plant, to reduce the amount of application of
weed controlling agents, to save the labor and the like. Thus
the present invention may provide a method for controlling weeds
which can increase options for herbicidal compounds to be
selected according to the property of the target plant.
Examples
Hereinafter, the present invention is further explained
with Examples in detail, but not limited thereto.

CA 02504960 2005-05-16
Example 1 (Production of recombinant tobacco plants into which
a cytochrome P450 gene has been introduced)
Plasmid pBI-NdG6-rSt-1609soy (Fig. 1) (described in
International Patent Publication W00304370) is a binary vector
plasmid to express the chimeric protein comprising the
chloroplast transit peptide sequence of soybean ( cv. Jack) RuBPCO
small subunit and cytochrome P450 having the amino acid sequence
of SEQ ID NO: 1 under the control of CR16G6 promoter (described
3.0 in International Patent Publication W000020613) . Plasmid
pliI-NdG6-rSt-1584 (Fig. 2) (described in International Patent
Publication W00304370) is a binary vector plasmid to express
the chimeric protein comprising the chloroplast transit peptide
sequence of soybean (cv. Jack) RuBPCO small subunit and
cytochrome P450 having the amino acid sequence of SEQ ID NO:
2 under the control of CR16G6 promoter (described in
International Patent Publication W000020613) .
These plasmids pHI-NdG6-rSt-1609soy and
pBI-NdG6-rSt-1584soy were introduced separately to
Agrobacterium tumefaciens LBA4404 strain (manufactured by
Clontech) . The resultant transformants were cultured on LB agar
medium ( 0 . 51 Yeast extract. 1.0% Bacto tryptone , 0.5% NaC1)
containing 300 p.g/L streptomycin, 100 p./L rifampicin and 25 /L
kanamycin, followed by selection of drug resistant colonies to
isolate a recombinant Agrobacterium strain having plasmid
36

CA 02504960 2005-05-16
pBI-NdG6-rSt-1609soy and a recombinant Agrobacterium strain
having plasmid pBI-NdG6-rSt-1584soy respectively.
Then, according to the method described in Manual for Gene
Manipulation of Plant (by Hirofumi Uchimiya, Kodan-sha
Scientific (1992) ) , gene introduction to tobacco was carried
out. The above recombinant Agrobacterium strains were each
cultured at 28 C overnight in LB liquid medium containing 300
tig/L streptomycin, 100 /L rifampicin and 25 ti/L kanamycin. To
the obtained liquid culture medium, leaf disks sampled from
aseptically-cultured tobacco (Nicotinia tabacum strain SR-1)
were dipped. The leaf disks were planted on MS agar medium (MS
inorganic salts, MS vitamins, 3% sucrose, and 0.8% agar;
Murashige T. and Skoog F., Physiol. Plant. (1962) 15, p473)
containing 0.1mg/L naphthalene acetic acid and 1.0 mg/L benzyl
aminopurine, and cultured in the light at room temperature for
2 days. Then, the leaf disks were washed with sterilized water,
and cultured for 7 days on MS agar medium containing 0.1mg/L
naphthalene acetic acid, 1.0 mg/L benzyl aminopurine and 500
mg/L cefotaxime. Next, the leaf disks were transplanted to and
cultured on MS agar medium containing 0. lmg/L naphthalene acetic
acid, 1.0 mg/L benzylaminopurine, 500 mg/L cefotaxime and 100
mg/L kanamycin. The culture was conducted continuously for 2
months while transplanting the leaf disks to fresh medium of
the same composition at intervals of 2 weeks. During that time,
the adventitious buds developed from the leaf disks were
37

CA 02504960 2005-05-16
transplanted to and rooted on MS agar medium containing 100 mg/L
kanamycin to obtain regenerated plants. Then, the regenerated
plants were transplanted to and cultured on MS agar medium
containing 100 mg/L kanamycin dispensed to culture pots
(Technopotmanufacturedby SUMITOMO BAKELITE Co., Ltd) to obtain
a recombinant tobacco individual into which the T-DNA region
of plasmid pBI-NdG6-rSt-1609soy has been introduced and a
recombinant tobacco individual into which the T-DNA region of
plasmidpBI-NdG6-rSt-1584soyhasbeenintroduced. Theobtained
individuals were transplanted to growing pots containing
horicultural soil (Kureha Engei Baido manufactured by Kureha
Chemical Industry Co., Ltd.) from the culture pots, acclimated
to the external environment in a growth chamber, then grown in
a greenhouse. Flowers were covered with paper bags during
flowering period to avoid crossing with other individuals, and
seeds were harvested from them.
Example 2 (Selection of the recombinant tobacco individual with
an accumulation of the cytochrome P450)
From the recombinant tobacco individuals obtained in
Example 1, recombinant tobacco individuals in which the protein
having the amino acid sequence of SEQ ID NO: 1 or 2 has been
accumulated in their leaves were selected by using Western
blotting method. Firstly, about 1 cm square of a leaf piece
of the recombinant tobacco to be assayed was sampled, and put
38

CA 02504960 2005-05-16
into 2 mL sampling tube. It was added one zirconia bead of 5
mm diameter (YTZ ball manufactured by NIKKATO CORPORATION)
therein and put the lid thereon, and then quickly frozen in liquid
nitrogen. Using a cell disruption apparatus (Mixer Mill MM300
manufactured by QIAGEN) , it was shaken twice at the rate of 30
times/second for 15 seconds to homogenize the sample. By adding
0.1 nth of sample buffer (PBS buffer (137 mM sodium chloride,
8.1 mM disodium hydrogenphosphate, 2.68 mM potassium chloride,
and 1.47 mM potassium dihydrogenphosphate) containing 1 mM
phenylmethylsulfonyl fluoride) and shaking, proteins were
extracted. Sampling one part of the extract, the concentration
of the protein in the extract was measured by using BIO-RAD Protein
Assay Kit (manufactured by BIO-RAD) and measuring absorbance
at 595 nm according to the protocol attached the kit using bovine
serum albumin as a standard. To the extract thus prepared from
the recombinant tobacco individual, it was mixed the same volume
of 2xSDS sample buffer (manufactured by Nakalai tesque) , heated
100 C for 3 minutes, and then cooled on ice. It was added into
the well of SDS-PAGE gel (PAG mini "Daiich- manufactured by
Daiichi Pure Chemicals Co., Ltd) such that 10 1.tg protein was
applied per 1 well. Electrophoresis was carried out in the
SDS-PAGE electrophoresis buffer
( tris(hydroxymethyl)aminomethane 15g, glycine 72g, and SDS
5g/L) at 40 rnA per gel for 1 hour. From this gel, the proteins
after the electrophoresis were transferred onto PVDF membrane
39

CA 02504960 2005-05-16
,
(Irnmobilon-P manufactured by Millipore) for 30 minutes at 10
V in transfer buffer of Bjerrum and Schafer-Nielsen (48 mM
tris(hydroxymethyl)amino methane, 39 mM glycine. and 20%
methanol) by using a semi-dry blotting device (Transblot SD cell
manufactured by BIO-RAD) according to the attached instruction
manual, The membrane was treated by using Immune blot kit
(mantgactured by BIO-RAD) and anti-rabbit IgG antibody labeled
with 'alkaline phosphatase, and then the coloring reaction was
carried out by using NBT/HCIP coloring system to detect a band
of thle protein extracted from the leaf of the recombinant tobacco
indiVidual. Firstly, the blocking treatment was carried out
by shaking the membrane gently in TBS buffer (20 mM Tris-HCl
(pH745) and 0.5 mM sodium chloride) containing 3% gelatin for
30 minutes at room temperature. Then, the membrane was washed
with TBS buffer for 5 minutes, and gently shaken for 1 hour at
room ,temperature with antiserum of the primary antibody diluted
3,000 fold with TBS buffer containing 0.05% Tween 20 to carry
out the primary antibody reaction. As the primary antibody,
the rabbit antiserum was used which was obtained by immunization
Of rabbit with the protein having the amino acid sequence of
SE() ID NO: 1 (described in International Patent Publication
W003040370). Next,themembranewaswashedtwicewithnSbuffer
containing 0.05% Tween 20 for 5 minutes, and then shaken gently
for 1 hour at room temperature with anti-rabbit IgG antibody
labeled with alkaline phosphatase (manufactured by Bio-Rad)

CA 02504960 2005-05-16
diluted 3,000 fold with TBS buffer containing 0.05% Tween 20
to carry out the second antibody reaction. Then, the membrane
was washed twice with TBS buffer containing 0.05% Tween 20 for
minutes and then the coloring reaction was carried out by using
5 AP coloring kit (manufactured by Bio-Rad) . The membrane after
coloring was kept after drying. By the above Western blotting
method, in 26 of 40 recombinant tobacco individuals to which
the plasmid pHI-NdG6-rSt-1609soy containing DNA having a
nucleotide sequence encoding the amino acid sequence of SEQ ID
NO: 1 has been introduced, it was detected relatively high amounts
of the protein having molecular weight of 44 kDa.
In 6 of 20 recombinant tobacco individuals to which the plasmid
pBI-NdG6-rSt-1584soy containing DNA having a nucleotide
sequence encoding the amino acid sequence of SEQ ID NO: 2 has
been introduced, it was detected relatively high amounts of the
protein having molecular weight of 44 kDa.
These recombinant tobacco individuals in which relatively
high amounts of the protein of 44 kDa was detected were selected
and seeds were harvested from the selected individuals to assay
copy number of the introduced gene.
Example 3 (Selection of a recombinant tobacco line to which 1
copy of the cytochrome P450 gene has been introduced)
Based on the principle that a kanamycin resistant gene
and a gene connected tandem to the resistant gene are linked
41

CA 02504960 2005-05-16
when these genes are introduced into a plant by Agrobacterium
method using a binary vector, from the recombinant tobacco
individuals selected in Example 2, tobacco lines in which 1 copy
of the introduced gene is located on one of homologous chromosomes
were further selected.
The seeds were harvested from To generation of the
recombinant tobacco individuals selectedinExample 2, and dipped
in a 5-fold dilution of sodium hypochlorite solution
(manufacturedbyNacalai tesque) for 15 minutes for sterilization.
About 50 seeds treated for sterilization were aseptically seeded
on MS agar medium containing 100 mg/L kanamycin, and cultured
at 25 C in the light to germinate aseptically. After about 2
weeks, germinated seedlings were observed to select tobacco lines
which indicate segregation rate of 3:1 at 5% significance level
by chi-square test. As the results, of 26 lines selected in
Example 2 from the recombinant tobacco individuals to which the
plasmid pHI-NdG6-rSt-1609soy has been introduced, 9 lines were
identified and selected as lines in which 1 copy of the introduced
gene is located on one of homologous chromosomes. Of 6 lines
selected in Example 2 from the recombinant tobacco individuals
to which the plasmid pHI-NdG6-rSt-1584soy has been introduced,
2 lines were identified and selected as lines in which 1 copy
of the introduced gene is located on one of homologous
chromosomes.
Next, T1-generation individuals of the above selected
42

CA 02504960 2005-05-16
lines were transplanted to growing pots containing horicultural
soil (KurehaEngei BaidomanufacturedbyKurehaChemical Industry
Co., Ltd.), acclimated to the external environment in a growth
chamber, then grown in a greenhouse. Flowers were covered with
paper bags during flowering period to avoid crossing with other
individuals, and seeds were harvested from them.
Example 4 (Selection of homozygote of the recombinant tobacco
line to which the cytochrome P450 gene has been introduced)
Seeds were harvested from the recombinant tobacco lines
#17, #19, #22, #23, #25, #29, #30, #34 and #40 which were selected
in Example 3 from among the lines to which the plasmid
pBI-NdG6-rSt-1609soy has been introduced. Also, seeds were
harvested from the recombinant tobacco lines #5 and #16 which
were selected in Example 3 from among the lines to which the
plasmid pBI-NdG6-rSt-1584soy has been introduced. Seeds of
each 4 individuals of the lines #17 and #25 of the recombinant
tobacco line into which the plasmid pl3I-NdG6-rSt-1609soy has
been introduced and the line #16 of the recombinant tobacco line
to which the plasmid pBI-NdG6-rSt-1584soy has been introduced
were seeded aseptically on MS agar medium containing 100 mg/L
kanamycin according the method described in Example 3. An
individual of which all seedlings show kanamycin resistance was
selected as a homozygote.
43

CA 02504960 2005-05-16
Example 5 (Spray test of the present herbicidal compound to the
recombinant tobacco line to which a DNA having a nucleotide
sequence encoding amino acid sequence of SEQ ID NO: 1 or 2 has
been introduced (ver. 1) )
Seeds of the homozygote lines selected in Example 4 ( seeds
of lines #17 and #25 of the recombinant tobacco to which plasmid
p8I-NdG6-rSt-1609soy has been introduced, and seeds of the line
1584soy#16 of the recombinant tobacco to which plasmid
p8I-NdG6-rSt-1584soy has been introduced) were aseptically
seeded on MS agar medium containing 100 mg/L kanamycin. Also,
seeds of the wild-type tobacco line SR-1 were aseptically seeded
on MS agar medium. After about 2 weeks, germinated seedlings
were observed.
Germinated individuals were transplanted to growing pots
containing horicultural soil (Kureha Engei Baido manufactured
by Kureha Chemical Industry Co., Ltd. ) , acclimated to the
external environment in a growth chamber, then grown for about
2 weeks at 23 C, 23 hours of day length in a growth chamber.
Thus obtained plants were applied to the spray test of the present
herbicidal compound, flufenpyr-ethyl.
Flufenpyr-ethyl was dissolved in Solvesso cocktail mixed
Solvesso 200 (manufactured by Valent ) and Sorpol 3816
(manufactured Sumitomo Chemical Co.. Ltd.) at the ratio of
87.5:10 such that flufenpyr-ethyl was respectively contained
0.89 mg or 1.78 mg in 0.5 mL Solvesso cocktail. The spray liquid
44

CA 02504960 2005-05-16
of flufenpyr-ethyl was prepared as the aqueous solution
containing the Solvesso cocktail of 2.5% concentration in which
the compound was dissolved and Agri dex of 1% concentration
(manufactured by Valent ) as adjuvant.
Spray of the spray liquid to the plant above described
was carried out, by using running automatic spray machine
(manufactured by Nambasekkei) , such that spray liquid 20 mL was
sprayed to the recombinant tobacco seedlings put at 0.9 square
meter of the sprayed area in a uniform way. After about 2 weeks,
the sensitivity of the applied recombinant tobacco line to
flufenpyr-ethyl was compared to the sensitivity of the wild-type
tobacco line SR-1 to flufenpyr-ethyl. In the above spray test,
4 individuals of the recombinant tobacco were used with respect
to each applied amount of flufenpyr-ethyl. The sensitivity of
the recombinant tobacco to flufenpyr- ethyl was decided by scoring
it based on the index below, and calculating the average of the
score of 4 individuals with respect to each recombinant tobacco
line and applied amount for it. The same spray test of wild-type
line SR-1 was carried out as a negative control. The results
are shown in Table 1.
(Scoring index based on the degree of phytotoxicity as dying
of the individual and browning or whitening of the leaves or
stems caused by compound spraying>
"0"; the case in that the individual was died;

CA 02504960 2005-05-16
"1"; the case in that phytotoxicity as browning or whitening
of the leaves or stems was caused, and the phytotoxicity seriously
affect the individual's growth, but it was not died;
"2": the case in that phytotoxicity as browning or whitening
of the leaves or stems was caused, but the phytotoxicity did
not seriously affect the individual's growth, but it was not
died; and
"3": the case in that phytotoxicity as browning or whitening
of the leaves or stems was small, or almost not observed.
Table 1
Appliedamountofflufenpyr-ethyl (mg/20
mL spray liquid)
Applied tobacco line 0.89 1.78
wild type SR-1 1.7 0.0
(negative control)
1609soy#17 (the 3.0 3.0
present plant)
1609soy#25 (the 3.0 3.0
present plant)
1584soy#16 (the 3.0 3.0
present plant)
The photos of the wild-type line SR-1 and the plants of
the invention (line 1609soy#17) grown for 14 days in a greenhouse
after spraying flufenpyr-ethyl (applied amount 1.78 mg/20 mL
spray liquid) are shown in Fig. 3.
Example 6 (Spray test of the present herbicidal compound to the
recombinant tobacco line to which a DNA having a nucleotide
46

CA 02504960 2005-05-16
sequence encoding the amino acid sequence of SEQ ID NO: 1 has
been introduced (ver. 2))
As to the homozygote line 1609soy#25 selected in Example
4 from among the recombinant tobacco lines to which a DNA having
a nucleotide sequence encoding the amino acid sequence of SEQ
ID NO: 1 has been introduced, and the wild-type tobacco line
SR-1, their sensitivities to the compound (I),
carfentrazone-ethyl and sulfentrazone were investigated
according to the method described in Example 5 (evaluation by
scoring index based on the degree of phytotoxicity as dying of
the individual and browning or whitening of the leaves or stems
caused by compound spraying) .
Each spray liquid of the above herbicidal compounds was
prepared as follows.
(1) In the case of the compound (I) : according to the method
described in Example 5, the spray liquid was prepared such that
0.089 mg, 0.223 mg or 0.446 mg of the compound ( I) was contained
in the spray liquid.
(2) In the case of carfentrazone-ethyl: the spray liquid was
prepared by dissolving dry flowable preparation of
carfentrazone-ethyl (AIMTH HERBICIDE manufactured by FMC,
containing 40%(w/w) of carfentrazone-ethyl) with Agri dex
(manufactured by Valent) 1% aqueous solution to be contained
0.446 mg, 0.893 mg or 4.46 mg of carfentrazone-ethyl in the spray
liquid.
47

CA 02504960 2005-05-16
(3) In the case of sulfentrazone: the spray liquid was prepared
by dissolving dry flowable preparation of sulfentrazone (Cover
TM 75DF manufactured by FMC, containing 75%(w/w) of
sulfentrazone) in Agri dex (manufactured by Valent) 1% aqueous
solution to be contained 0.446 mg, 0.893 mg, 1.78 mg or 4.46
mg of sulfentrazone in the spray liquid.
As the results, in the plant (line 1609soy#17) to which
theaboveeachherbicidalcompoundwas applied, the phytotoxicity
was reduced and remarkable improvement of the resistance was
recognized as compared to the wild type line SR-1 (negative
control). The results of the spray test of carfentrazone-ethyl
are shown in Table 2.
Table 2
Applied amount of carfentrazone-ethyl
(mg/20 mL spray liquid)
Applied tobacco line 0.446 0.893 4.46
wild type SR-1 1.0 0.0 0.0
(negative control)
1609soy#25 (the 2.5 1.8 1.5
present plant)
Example 7 (Spray test of the present herbicidal compound to the
recombinant soybean line to which a DNA having a nucleotide
sequence encoding the amino acid sequence of SEQ ID NO: 1 has
been introduced)
By digesting plasmid pUCrSt1609soy described in Example
48

CA 02504960 2005-05-16
75 of W00304370 which contains a DNA having a nucleotide sequence
encoding the amino acid sequence of SEQ ID NO: 1 with restriction
enzymes Barn HI and Sac I, the DNA containing the nucleotide
sequence encoding the amino acid sequence of SEQ ID NO: 1 was
isolated. By inserting the DNA between Barn HI cleavage site
and Sac I cleavage site of plasmid pBI221 (manufactured by
Clontech, GenBank Association Number: AF502128), plasmid
pSUM-35S-rSt-1609soy (Fig. 4) was constructed wherein the
chimeric DNA, in which the above DNA was connected in frame of
codons immediately after the nucleotide sequence encoding the
chloroplast transit peptide of soybean (cv. Jack) RuBPC small
subunit, was connected downstream of 35S promoter of cauliflower
mosaicvirus. TheplasmidpSUM-35S-rSt-1609soy,andhygromycin
selective marker plasmid containing a DNA in which APH4 gene
derived from E. coil (GenBank Accession Number: V01499) was
connected downstream of the promoter derived from plasmid
pG8CRG1-2 described in EP0976832, were mixed at the ratio of
1:1, and introduced into soybean raspberry-shaped somatic embryo
according to the method described in Example 75 of W00304370.
By selecting the soybean raspberry-shaped somatic embryo on a
selection medium containing hygromycin according to the method
described in Example 47 of W00304370, it was obtained 155 lines
of soybean raspberry-shaped somatic embryos being able to grow
on the selection medium and containing a chromosome to which
the DNA having the nucleotide sequence encoding the amino acid
49

CA 02504960 2005-05-16
sequence of SEQ ID NO: 1 has been introduced.
By PCR method described below, it was confirmed that the
DNA having the nucleotide sequence encoding the amino acid
sequence of SEQ ID NO: 1 was introduced into chromosome of the
selected somatic embryo. After sampling the somatic embryo
selected on the selection medium, 40 RL PrepMan Ultra Reagent
(manufactured by Applied Biosystems) was added thereto. The
obtained mixture was heated at 100 C for 10 minutes, and then
cooled. By centrifuging the cooled mixture at 15,000rpm for
I minute, the supernatant was obtained. The obtained
supernatant was used as chromosomal DNA solution to be a template
in the following PCR reaction. Using 1RL of the chromosomal
DNA solution as the template, and DNA polymerase Ex-Taq-HS
(manufactured by TAKARA BIO INC.), total 20 RL of the reaction
mixture was prepared according to the attached protocol. The
prepared reaction mixture was kept at 94 C for 2 minutes, and
repeated 30 times the cycle which was a set of the steps to keep
at 94 C for 30 seconds, then at 58 C for 30 seconds, then at
72 C for 1 minute, and finally kept at 72 C for 2 minutes. As
the primers, two kinds of the synthetic oligonucleotide (SEQ
ID NO: 3 and SEQ ID NO: 4) were used. 10 RL of the reaction
mixture after the reaction was applied to the electrophoresis
using an agarose gel containing 1.5% agarose in TBE buffer, and
then stained the agarose gel with ethidium bromide to detect
under the irradiation of 254 nm of ultraviolet a 503bp DNA

CA 02504960 2005-05-16
amplified in the above PCR reaction. As the results, it was
confirmed that the DNA having the nucleotide sequence encoding
the amino acid sequence of SEQ ID NO: 1 was introduced.
From the selected somatic embryos, the individuals were
regenerated according to the method described in Example 47 of
W00304370. The concentration of agar in the development medium
was 1.0 ( w/v ) % . The individual plantlets rooting and developing
leaves were acclimated to the external environment in a growth
chamber and then grown in a greenhouse according to the methods
described in Example 47 of W00304370. Seeds were harvested from
the fertile individuals. Thus, 79 lines of the recombinant
soybean to which pSUM-35S-rSt-1609soy has been introduced was
obtained. Leaves were sampled from the individuals, and 20 lines
of the recombinant soybean in which the 44 kDa protein having
the amino acid sequence of SEQ ID NO: 1 was accumulated in leaves
thereof were selected according to the method described in
Example 2. Among them, it was detected relatively high amounts
of the protein in the lines J16, J18, 126 and J28.
Seeds of these lines were seeded and grown in growing pots
containing horicultural soil (Kureha Engei Baido manufactured
by Kureha Chemical Industry Co . , Ltd.) When trifoliate leaves
were developed after germination, the seedlings were
transplanted to growing pots containing the soil prepared by
mixing equal amount of the Kureha Engei Baido and field soil,
and then grown in a greenhouse according to the method of Example
51

CA 02504960 2005-05-16
17 of W00304370 to obtain seeds of T2 generation of each line.
Among the obtained T2 generations, seeds of T2 generation of
the line 318 (seeds of the recombinant soybean) were seeded in
growing pots containing horicultural soil (Kureha Engei Baido
manufactured by Kureha Chemical Industry Co., Ltd.) and grown.
According to the above method described in Example 5, it was
sprayed carfentrazone-ethyl to the seedling on the 21st day after
seeding, and compared the sensitivity to carfentrazone-ethyl
of the recombinant soybean with the sensitivity to
carfentrazone-ethyl of wild-type soybean line (cv. Jack) at 2
weeks after spraying. The spray liquid of the above herbicidal
compound was prepared as follows.
(The spray liquid of the present herbicidal compound)
The spray liquid was prepared by diluting dry flowable
preparation of carfentrazone-ethyl (AIMTm HERBICIDE
manufactured by FMC, containing 40%(w/w) of
carfentrazone-ethyl) with Agri dex (manufactured by Valent) 1%
aqueous solution to be contained 1.79 mg, 3.57 mg or 7.14 mg
of carfentrazone-ethyl in the spray liquid.
The sensitivity of the recombinant soybean to
careentrazone-ethyl was decided by scoring it based on the index
below, and calculating the average of the scores with respect
to each recombinant soybean line and applied amount for it. The
same spray test of the wild-type soybean line (cv. Jack) was
52

CA 02504960 2005-05-16
*
carried out as a negative control.
As the results, in the present plant (line J18) to which
the above herbicidal compound was applied, the phytotoxicity
was reduced and remarkable improvement of the resistance was
recognized as compared to the wild-type plant cv. Jack (negative
control). The results of the spray test of carfentrazone-ethyl
are shown in Table 3.
<Scoring index based on the degree of phytotoxicity as dying
of the individual and browning or whitening of the leaves or
stems caused by compound spraying>
"0": the case in that the individual was died;
"1": the case in that phytotoxicity as browning or whitening
of the leaves or stems was caused, and the phytotoxicity
seriously affect the individual's growth, but it was not died;
"2": the case in that phytotoxicity as browning or whitening
of the leaves or stems was caused, but the phytotoxicity did
not seriously affect the individual's growth, but it was not
died; and
"3": the case in that phytotoxicity as browning or whitening
of the leaves or stems was small, or almost not observed.
53

CA 02504960 2005-05-16
Table 3
Applied soybean line Applied amount of carfentrazone-ethyl
(mg/20 mL spray liquid)
0 1.79 3.57 7.14
wild type cv. Jack 3.0 1.0 0.9 0.3
(negative control)
318 (the present plant) 3.0 1.8 1.4 0.9
The photos of the wild-type line cv. Jack and the present
plant (the recombinant soybean line J18) grown for 15 days in
a greenhouse after spraying carfentrazone-ethyl (applied amount
3.57 mg/20 mL spray liquid) are shown in Fig. 5.
Free text in Sequence Listing
SEQ ID No: 3
Designed oligonucleotide primer for PCR
SEQ ID No: 4
Designed oligonucleotide primer for PCR
54

CA 02504960 2005-06-06
SEQUENCE LISTING
<110> Sumitomo Chemical Co., Ltd.
<120> Method for controlling weeds
<130> 18117-0
<140> CA 2,504,960
<141> 2005-05-16
<150> JP 2004/146019
<151> 2004-05-17
<150> JP 2005/068714
<151> 2005-03-11
<160> 4
<210> 1
<211> 398
<212> PRT
<213> Streptomyses steffisburgensis IF013446T
<400> 1
Met Ser Asp Thr Thr Ala Pro Val Ala Phe Pro Gin Ser Arg Thr Cys
1 5 10 15
Pro Tyr His Pro Pro Ala Ala Tyr Glu Pro Leu Arg Ala Glu Arg Pro
20 25 30
Leu Thr Arg Ile Thr Leu Phe Asp Gly Arg Glu Ala Trp Leu Val Ser
35 40 45
Gly His Ala Thr Ala Arg Ala Leu Leu Ala Asp Pro Arg Leu Ser Ser
50 55 60
Asp Arg Asp Arg Pro Gly Phe Pro Ala Pro Thr Ala Arg Phe Ala Gly
65 70 75 80
Ile Arg Asn Arg Arg Thr Ala Leu Leu Gly Val Asp Asp Pro Glu His
85 90 95
Arg Val Gin Arg Arg Met Val Ala Gly Asp Phe Thr Leu Lys Arg Ala
100 105 110
Ala Gly Leu Arg Pro Arg Ile Gin Arg Ile Val Asp Arg Arg Leu Asp
115 120 125
Ala Met Ile Ala Gin Gly Pro Pro Ala Asp Leu Val Ser Ser Phe Ala
130 135 140
Leu Pro Val Pro Ser Met Val Ile Cys Ala Leu Leu Gly Val Pro Tyr
145 150 155 160
Ala Asp His Asp Phe Phe Glu Thr Gin Ser Arg Arg Leu Leu Arg Gly
165 170 175
Pro Gin Thr Ala Asp Val Met Asp Ala Arg Ala Arg Leu Asp Glu Tyr
180 185 190
Phe Gly Glu Leu Ile Asp Arg Lys Arg Lys Glu Pro Gly Ala Gly Leu
195 200 205
Leu Asp Asp Leu Val Gin Arg Gin Leu Arg Asp Gly Ala Leu Asp Arg
210 215 220
Glu Gly Leu Ile Ala Leu Ala Leu Ile Leu Leu Val Ala Gly His Glu
225 230 235 240
Thr Thr Ala Asn Met Ile Ser Leu Gly Thr Phe Thr Leu Leu Gin His
245 250 255
Pro Glu Arg Leu Ala Glu Leu Arg Ala Asp Pro Arg Leu Leu Pro Ala
260 265 270

CA 02504960 2005-06-06
Ala Val Glu Glu Leu Met Arg Met Leu Ser Ile Ala Asp Gly Leu Leu
275 280 285
Arg Leu Ala Val Glu Asp Ile Glu Val Ala Gly Thr Thr Ile Arg Lys
290 295 300
Gly Asp Gly Val Val Phe Leu Thr Ser Val Ile Asn Arg Asp Glu Thr
305 310 315 320
Val Tyr Pro Glu Pro Asp Thr Leu Asp Trp His Arg Ser Ala Arg His
325 330 335
His Val Ala Phe Gly Phe Gly Ile His Gln Cys Leu Gly Gln Asn Leu
340 345 350
Ala Arg Ala Glu Leu Glu Ile Ala Leu Trp Thr Leu Phe Asp Arg Leu
355 360 365
Pro Thr Leu Arg Leu Ala Ala Pro Ala Glu Glu Ile Ala Phe Lys Pro
370 375 380
Gly Asp Thr Ile Gln Gly Met Leu Glu Leu Pro Val Thr Trp
385 390 395
<210> 2
<211> 398
<212> PRT
<213> Streptomyses roseorubens IF013682T
<400> 2
Met Thr Asp Thr Thr Ala Pro Val Ala Phe Pro Gln Ser Arg Thr Cys
1 5 10 15
Pro Tyr His Pro Pro Ala Ala Tyr Glu Pro Leu Arg Ala Glu Arg Pro
20 25 30
Leu Thr Arg Ile Thr Leu Phe Asp Gly Arg Glu Ala Trp Leu Val Ser
35 40 45
Gly His Ala Thr Ala Arg Ala Leu Leu Ala Asp Pro Arg Leu Ser Ser
50 55 60
Asp Arg Asp Arg Pro Gly Phe Pro Thr Pro Thr Ala Arg Phe Ala Gly
65 70 75 80
Ile Arg Asn Arg Arg Thr Ala Leu Leu Gly Val Asp Asp Pro Glu His
85 90 95
Arg Ala Gln Arg Arg Met Val Val Gly Asp Phe Thr Leu Lys Arg Ala
100 105 110
Ala Ala Leu Arg Pro Arg Ile Gln Arg Ile Val Asp Glu Arg Leu Asp
115 120 125
Ala Met Ile Ala Gln Gly Pro Pro Ala Asp Leu Val Ser Ala Phe Ala
130 135 140
Leu Pro Val Pro Ser Met Val Ile Cys Ala Leu Leu Gly Val Pro Tyr
145 150 155 160
Ala Asp His Asp Phe Phe Glu Ala Gln Ser Arg Arg Leu Leu Arg Gly
165 170 175
Pro Gly Thr Ala Asp Val Gln Asp Ala Arg Ser Arg Leu Glu Glu Tyr
180 185 190
Phe Gly Glu Leu Ile Asp Arg Lys Arg Glu Asp Pro Gly Thr Gly Leu
195 200 205
Leu Asp Asp Leu Val Gln Arg Gln Pro Gly Asp Gly Gly Pro Asp Arg
210 215 220
Glu Gly Leu Ile Ala Met Ala Leu Ile Leu Leu Val Ala Gly His Glu
225 230 235 240
Thr Thr Ala Asn Met Ile Ser Leu Gly Thr Phe Thr Leu Leu Gln His
245 250 255
Pro Glu Arg Leu Ala Glu Leu Arg Ala Asp Ser Glu Val Met Pro Ala
260 265 270
Ala Val Glu Glu Leu Met Arg Leu Leu Ser Ile Ala Asp Gly Leu Leu
275 280 285
56

CA 02504960 2005-06-06
Arg Ile Ala Val Glu Asp Val Glu Val Ala Gly Thr Thr Ile Arg Ala
290 295 300
Gly Glu Gly Val Val Phe Ala Thr Ser Val Ile Asn Arg Asp Glu Thr
305 310 315 320
Val Phe Ala Glu Pro Asp Thr Leu Asp Trp Ser Arg Pro Ala Arg His
325 330 335
His Val Ala Phe Gly Phe Gly Ile His Gin Cys Leu Gly Gin Asn Leu
340 345 350
Ala Arg Ala Glu Leu Glu Ile Ala Leu Gly Thr Leu Phe Gly Arg Leu
355 360 365
Pro Thr Leu Arg Leu Ala Ala Pro Pro Asp Glu Ile Pro Phe Lys Pro
370 375 380
Gly Asp Thr Ile Gin Gly Met Leu Glu Leu Pro Val Thr Trp
385 390 395
<210> 3
<211> 25
<212> DNA
<213> Artificial Sequence
<220>
<223> Designed oligonucleotide primer for PCR
<400> 3
aggctttcat ctgatcgtga cagac 25
<210> 4
<211> 25
<212> DNA
<213> Artificial Sequence
<220>
<223> Designed oligonucleotide primer for PCR
<400> 4
atcagacctt ccctgtctaa tgctc 25
57

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2014-06-17
(22) Filed 2005-05-16
(41) Open to Public Inspection 2005-11-17
Correction of Dead Application 2007-07-19
Examination Requested 2010-05-10
(45) Issued 2014-06-17
Deemed Expired 2020-08-31

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $400.00 2005-05-16
Registration of a document - section 124 $100.00 2005-07-12
Maintenance Fee - Application - New Act 2 2007-05-16 $100.00 2007-04-12
Maintenance Fee - Application - New Act 3 2008-05-16 $100.00 2008-04-30
Maintenance Fee - Application - New Act 4 2009-05-19 $100.00 2009-04-09
Maintenance Fee - Application - New Act 5 2010-05-17 $200.00 2010-04-08
Request for Examination $800.00 2010-05-10
Maintenance Fee - Application - New Act 6 2011-05-16 $200.00 2011-05-02
Maintenance Fee - Application - New Act 7 2012-05-16 $200.00 2012-04-04
Maintenance Fee - Application - New Act 8 2013-05-16 $200.00 2013-04-08
Final Fee $300.00 2014-04-03
Maintenance Fee - Application - New Act 9 2014-05-16 $200.00 2014-04-11
Maintenance Fee - Patent - New Act 10 2015-05-19 $250.00 2015-04-22
Maintenance Fee - Patent - New Act 11 2016-05-16 $250.00 2016-04-20
Maintenance Fee - Patent - New Act 12 2017-05-16 $250.00 2017-04-26
Maintenance Fee - Patent - New Act 13 2018-05-16 $250.00 2018-04-26
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
SUMITOMO CHEMICAL COMPANY, LIMITED
Past Owners on Record
MATSUSHIMA, YUTAKA
NAGASAWA, AKITSU
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Representative Drawing 2005-10-24 1 5
Abstract 2005-05-16 1 17
Description 2005-05-16 59 1,895
Claims 2005-05-16 4 96
Description 2005-06-06 57 1,888
Claims 2005-06-06 4 96
Cover Page 2005-11-01 1 34
Description 2012-06-14 62 2,028
Claims 2012-06-14 4 137
Claims 2013-01-30 3 79
Description 2013-01-30 62 2,030
Claims 2013-10-09 3 78
Representative Drawing 2014-05-27 1 11
Cover Page 2014-05-27 1 35
Correspondence 2005-05-25 1 25
Correspondence 2005-07-19 2 41
Assignment 2005-05-16 3 80
Prosecution-Amendment 2005-05-16 1 68
Prosecution-Amendment 2005-07-12 1 51
Prosecution-Amendment 2005-06-06 8 221
Assignment 2005-07-12 2 59
Correspondence 2005-08-23 1 35
Prosecution-Amendment 2005-07-29 4 140
Prosecution-Amendment 2006-01-04 1 62
Correspondence 2007-05-01 1 24
Correspondence 2007-07-17 1 11
Correspondence 2007-07-19 1 16
Prosecution-Amendment 2010-05-10 1 45
Drawings 2005-05-16 2 22
Prosecution-Amendment 2011-12-14 3 102
Prosecution-Amendment 2012-06-14 13 413
Prosecution-Amendment 2012-07-31 2 69
Prosecution-Amendment 2013-01-30 8 244
Prosecution-Amendment 2013-08-07 2 41
Prosecution-Amendment 2013-10-09 3 80
Correspondence 2014-04-03 1 31

Biological Sequence Listings

Choose a BSL submission then click the "Download BSL" button to download the file.

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.

Please note that files with extensions .pep and .seq that were created by CIPO as working files might be incomplete and are not to be considered official communication.

BSL Files

To view selected files, please enter reCAPTCHA code :